Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Angewandte Chemie (International Ed. in English)
|
April 27, 2023
Photosynthetic Fixation of CO<sub>2</sub> in Alkenes by Heterogeneous Photoredox Catalysis with Visible Light
Tao Yuan, Ziwei Wu, Senmao Zhai, et al.
Organic Letters
|
December 6, 2024
Multicomponent Heterogeneous Semiconductor Photocatalytic Sulfinylsulfonylation of Alkenes with Alkyl Iodides and SO<sub>2</sub>
Pan Zhou, Yongxin Zhang, Jiarong Chen, et al.
Chemical Science
|
January 23, 2026
Electrosynthesis of 2,5-furandicarboxylic acid from 5-hydroxymethylfurfural: mechanisms, advanced catalysts, and reaction microenvironments
Jiacheng Zhang, Siping Wang, Jiaqing Liu, et al.
BMC Cardiovascular Disorders
|
September 7, 2020
The preablation monocyte/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation
She-An Chen, Man-Man Zhang, Meifang Zheng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 13, 2025
Linoleic Acid Potentiates Response to Chemotherapy in Biliary Tract Cancer Through RARγ Activation
Yinye Yao, Chunjing Xu, Yongfu Shao, et al.
Science Bulletin
|
March 1, 2026
Redox-pathway steering enables photocatalytic valorization of CO<sub>2</sub> and 1-phenylethanol with record quantum efficiency
Xinyu Xu, Jia Zhou, Meiyan Guo, et al.
Signal Transduction and Targeted Therapy
|
April 26, 2026
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 study
Lin Gui, Haifeng Liu, Huaqing Wang, et al.
Blood Cancer Journal
|
March 18, 2026
Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)
Juying Wei, Qingqing Cai, Liling Zhang, et al.
Eclinicalmedicine
|
September 2, 2025
Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study
Junning Cao, Guangliang Chen, Lihua Qiu, et al.
The Lancet. Oncology
|
December 13, 2023
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
Yuqin Song, Luis Malpica, Qingqing Cai, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Angewandte Chemie (International Ed. in English)
|
April 27, 2023
Photosynthetic Fixation of CO<sub>2</sub> in Alkenes by Heterogeneous Photoredox Catalysis with Visible Light
Tao Yuan, Ziwei Wu, Senmao Zhai, et al.
Organic Letters
|
December 6, 2024
Multicomponent Heterogeneous Semiconductor Photocatalytic Sulfinylsulfonylation of Alkenes with Alkyl Iodides and SO<sub>2</sub>
Pan Zhou, Yongxin Zhang, Jiarong Chen, et al.
Chemical Science
|
January 23, 2026
Electrosynthesis of 2,5-furandicarboxylic acid from 5-hydroxymethylfurfural: mechanisms, advanced catalysts, and reaction microenvironments
Jiacheng Zhang, Siping Wang, Jiaqing Liu, et al.
BMC Cardiovascular Disorders
|
September 7, 2020
The preablation monocyte/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation
She-An Chen, Man-Man Zhang, Meifang Zheng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 13, 2025
Linoleic Acid Potentiates Response to Chemotherapy in Biliary Tract Cancer Through RARγ Activation
Yinye Yao, Chunjing Xu, Yongfu Shao, et al.
Science Bulletin
|
March 1, 2026
Redox-pathway steering enables photocatalytic valorization of CO<sub>2</sub> and 1-phenylethanol with record quantum efficiency
Xinyu Xu, Jia Zhou, Meiyan Guo, et al.
Signal Transduction and Targeted Therapy
|
April 26, 2026
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 study
Lin Gui, Haifeng Liu, Huaqing Wang, et al.
Blood Cancer Journal
|
March 18, 2026
Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)
Juying Wei, Qingqing Cai, Liling Zhang, et al.
Eclinicalmedicine
|
September 2, 2025
Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study
Junning Cao, Guangliang Chen, Lihua Qiu, et al.
The Lancet. Oncology
|
December 13, 2023
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
Yuqin Song, Luis Malpica, Qingqing Cai, et al.
Page
of 4